Application of urine immunofixation electrophoresis in prognostic evaluation of hematopoietic stem cell transplantation in patients with myeloma.

Pak J Med Sci · 2022 · PMC8713238 · PMID 35035446

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

11 Patients with MM usually have a median survival time of 3-4 years, and their incidence accounts for about 1% of malignant tumors, showing an increasing trend year by year. 12 Autologous hematopoietic stem cell transplantation has been extensively applied in the treatment of MM.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.